Bioventix PLC
LSE:BVXP

Watchlist Manager
Bioventix PLC Logo
Bioventix PLC
LSE:BVXP
Watchlist
Price: 3 200 GBX -3.76% Market Closed
Market Cap: 167m GBX
Have any thoughts about
Bioventix PLC?
Write Note

Bioventix PLC
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioventix PLC
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Bioventix PLC
LSE:BVXP
Free Cash Flow
ÂŁ8m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Free Cash Flow
-$160.5m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Free Cash Flow
-ÂŁ144.3m
CAGR 3-Years
-68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Free Cash Flow
-$203.5m
CAGR 3-Years
-109%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Free Cash Flow
-ÂŁ2.5m
CAGR 3-Years
66%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Free Cash Flow
ÂŁ5.1m
CAGR 3-Years
-47%
CAGR 5-Years
0%
CAGR 10-Years
-15%
No Stocks Found

Bioventix PLC
Glance View

Market Cap
167m GBX
Industry
Biotechnology

Bioventix Plc engages in the development and supply of antibodies. The company is headquartered in Farnham, Surrey and currently employs 17 full-time employees. The company went IPO on 2014-04-29. The principal activity of the Company is the development and supply of antibodies. The firm specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The firm offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The firm also supplies antibody products and services to multinational clinical diagnostics companies. The firm sells its products through direct sales and through distributors.

BVXP Intrinsic Value
3 026.52 GBX
Overvaluation 5%
Intrinsic Value
Price

See Also

What is Bioventix PLC's Free Cash Flow?
Free Cash Flow
8m GBP

Based on the financial report for Dec 31, 2023, Bioventix PLC's Free Cash Flow amounts to 8m GBP.

What is Bioventix PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
6%

Over the last year, the Free Cash Flow growth was 0%. The average annual Free Cash Flow growth rates for Bioventix PLC have been 6% over the past three years , 6% over the past five years .

Back to Top